診療科・部門

研究実績

令和4年3月改訂

誌上発表

2023

英文論文:13編

  • Matsuzuka T, Tsukahara K, Yoshimoto S, Chikamatsu K, Shiotani A, Oze I, Murakami Y, Shinozaki T, Enoki Y, Ohba S, Kawakita D, Hanai N, Koide Y, Sawabe M, Nakata Y, Fukuda Y, Nishikawa D, Takano G, Kimura T, Oguri K, Hirakawa H, Hasegawa Y:  Predictive factors for dissection-free sentinel node micrometastases in early oral squamous cell carcinoma. Sci Rep, 13(1):6188,2023.
  • Nishikawa D, Beppu S, Suzuki H, Terada H, Sawabe M, Hanai N: A novel technique in transoral robotic surgery: A case report of rotating and switching technique. Int J Med Robot, 19(4):e2520,2023.
  • Suzuki H, Sasaki E, Tamaki T, Kodaira T, Nishio M, Nishikawa D, Beppu S, Terada H, Sawabe M, Hanai N: Association Between 18F-Fluorodeoxyglucose Uptake and Mutation Status of Epidermal Growth Factor Receptor in Sinonasal Tract Cancer. Anticancer Res, 43(7):3247-3253,2023.
  • Kobayashi K, Hanai N, Yoshimoto S, Saito Y, Homma A: Current topics and management of head and neck sarcomas. Jpn J Clin Oncol, 53(9):743-756,2023.
  • Shimoda H, Teshima M, Murase T, Nagao T, Kusafuka K, Nakaguro M, Urano M, Taguchi KI, Yamamoto H, Kano S, Tada Y, Tsukahara K, Okami K, Onitsuka T, Fujimoto Y, Kawakita D, Sakurai K, Hanai N, Nagao T, Kawata R, Hato N, Nibu KI, Inagaki H: Prognostic scores for patients with salivary adenoid cystic carcinoma without lymph node metastasis. Oral Oncol, 145:106491,2023.
  • Ueda K, Murase T, Kawakita D, Nagao T, Kusafuka K, Nakaguro M, Urano M, Yamamoto H, Taguchi KI, Kano S, Tada Y, Tsukahara K, Okami K, Onitsuka T, Fujimoto Y, Sakurai K, Hanai N, Nagao T, Kawata R, Hato N, Nibu KI, Inagaki H: The Landscape of MYB/MYBL1- and Peri-MYB/MYBL1-Associated Rearrangements in Adenoid Cystic Carcinoma. Mod Pathol, 36(10):100274,2023.
  • Sawabe M, Kawakita D, Oze I, Iwasaki S, Hasegawa Y, Murakami S, Ito H, Hanai N, Matsuo K: The Heterogeneous Impact of Prediagnostic Folate Intake for Fluorouracil-Containing Induction Chemotherapy for Head and Neck Cancer. Cancers(Basel), 15(21):5150,2023.
  • Suzuki H, Haimoto S, Inaba Y, Tachibana H, Takanari K, Ando M, Yoshizawa K, Hanai N: Peptide Receptor Radionuclide Therapy for Recurrent Olfactory Neuroblastoma After Cranioplasty for Surgical Infection: A Case Report. Anticancer Res, 43(12):5723-5728,2023.
  • Homma A, Ando M, Hanai N, Harada H, Honma Y, Kanda T, Kano S, Kawakita D, Kiyota N, Kizawa Y, Nakagawa M, Ogawa T, Shinomiya H, Shinozaki T, Suzuki M, Tsuji T, Yasuda K, Zenda S, Kodaira T, Kirita T, Nibu KI: Summary of Japanese clinical practice guidelines for head and neck cancer – 2022 update edited by the Japan society for head and neck cancer. Auris Nasus Larynx, 51(1):174-188,2024.
  • Ishihara H, Nishikawa D, Muraoka D, Masago K, Beppu S, Terada H, Matsushita H, Hanai N: Changes in serum DAMPs and cytokines/chemokines during near-infrared photoimmunotherapy for patients with head and neck cancer. Cancer Med, 13(1):e6863, 2023.
  • Sato Y, Takahashi S, Toshiyasu T, Tsuji H, Hanai N, Homma A: Squamous cell carcinoma of the eyelid. Jpn J Clin Oncol, 54(1):4-12,2024.
  • Ariizumi Y, Hanai N, Asakage T, Seto A, Tomioka T, Miyabe J, Kessoku H, Mukaigawa T, Omura G, Teshima M, Nishikawa D, Saito Y, Asada Y, Fujisawa T, Makino T, Nishino H, Sano D, Nakahira M, Tokashiki K, Uemura H, Ueda T, Sakai A, Masuda M, Tsujikawa T, Hiei Y, Nishio N, Matsui H, Kiyota N, Homma A: Extent of thyroidectomy and paratracheal lymph node dissection in total pharyngolaryngectomy for pyriform sinus cancer, and recurrence, survival, and postoperative hypoparathyroidism: A multicenter retrospective study. Head Neck, 46(2):269-281,2024.
  • Kodama H, Kadowaki S, Nakazawa T, Matsubara Y, Narita Y, Honda K, Masuishi T, Taniguchi H, Ando M, Koide Y, Tachibana H, Kodaira T, Sawabe M, Terada H, Beppu S, Nishikawa D, Suzuki H, Hanai N, Muro K: Safety and Efficacy of Gemcitabine Plus Cisplatin Against Recurrent/Metastatic Nasopharyngeal Carcinoma: A Retrospective Study. Anticancer Res, 44(3):1227-1232,2024.

邦文論文・商業誌・学会誌その他:13編

2022

英文論文:13編

  • Imamura Y, Kiyota N, Tahara M, Hanai N, Asakage T, Matsuura K, Ota I, Saito Y, Sano D, Kodaira T, Motegi A, Yasuda K, Takahashi S, Yokota T, Okano S, Tanaka K, Onoe T, Ariizumi Y, Homma A: Systemic therapy for salivary gland malignancy: current status and future perspectives. Jpn J Clin Oncol, 52(4):293-302, 2022.
  • Nishikawa D, Hanai N, Ozawa T, Kitahara T, Hasegawa Y: Role of Human Papilloma Virus and Lifestyle Factors in Overall Survival of Patients with Oropharyngeal Squamous Cell Carcinoma. Medicina (Kaunas), 58(4):557, 2022.
  • Hirakawa H, Matsuzuka T, Uemura H, Yoshimoto S, Miura K, Shiotani A, Sugasawa M, Homma A, Yokoyama J, Tsukahara K, Yoshizaki T, Hanai N, Suzuki H, Suzuki M, Hasegawa Y: Auris Nasus Larynx, 49(4):680-689, 2022.
  • Hanai N, Beppu S, Nishikawa D, Terada H, Nishikawa D, Sawabe M: A novel procedure of secondary voice prosthesis insertion from the inside out: The modified Fukuhara method. Auris Nasus Larynx, 49(4):658-662, 2022.
  • Kiyota N, Tahara M, Mizusawa J, Kodaira T, Fujii H, Yamazaki T, Mitani H, Iwae S, Fujimoto Y, Onozawa Y, Hanai N, Ogawa T, Hara H, Monden N, Shimura E, Minami S, Fujii T, Tanaka K, Homma A, Yoshimoto S, Oridate N, Omori K, Ueda T, Okami K, Ota I, Shiga K, Sugasawa M, Asakage T, Saito Y, Murono S, Nishimura Y, Nakamura K, Hayashi R; Head and Neck Cancer Study Group of the Japan Clinical Oncology Group (JCOG-HNCSG):Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial. J Clin Oncol, 40(18):1980-1990, 2022.
  • Saito Y, Homma A, Kiyota N, Tahara M, Hanai N, Asakage T, Matsuura K, Ota I, Yokota T, Sano D, Kodaira T, Motegi A, Yasuda K, Takahashi S, Tanaka K, Onoe T, Okano S, Imamura Y, Ariizumi Y, Hayashi R: Human papillomavirus-related oropharyngeal carcinoma. Jpn J Clin Oncol, 52(7):692-698, 2022.
  • Tsuzuki H, Suzuki H, Tamaki T, Sone M, Hanai N: Detection Ability of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Clinical T Classification of Synchronous Esophageal Cancer in Pharyngeal Cancer. Anticancer Res, 42(9):4597-4602,2022.
  • Nishikawa D, Suzuki H, Beppu S, Terada H, Sawabe M, Hanai N: Near-Infrared Photoimmunotherapy for Oropharyngeal Cancer. Cancers (Basel), 14(22):5662, 2022.
  • Suzuki H, Beppu S, Nishikawa D, Terada H, Sawabe M, Hanai N: Lymph Node Ratio in Head and Neck Cancer with Submental Flap Reconstruction. Biomedicines, 10(11):2923, 2022.
  • Takahashi S, Oridate N, Tanaka K, Shimizu Y, Fujimoto Y, Matsumoto K, Yokota T, Yamazaki T, Takahashi M, Ueda T, Hanai N, Yamaguchi H, Hara H, Yoshizaki T, Yasumatsu R, Nakayama M, Shiga K, Fujii T, Mitsugi K, Takahashi K, Nohata N, Gumuscu B, Swaby RF, Tahara M: First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048. Int J Clin Oncol, 27(12):1805-1817, 2022.
  • Suzuki H, Takano G, Tsukushi S, Ando M, Yatabe Y, Kodaira T, Nishikawa D, Beppu S, Hasegawa Y, Hanai N: Impact of age for overall survival in head and neck sarcoma.  Medicine (Baltimore), 102(7):e32966,2023.
  • Matsuzuka T, Tsukahara K, Yoshimoto S, Chikamatsu K, Shiotani A, Oze I, Murakami Y, Shinozaki T, Enoki Y, Ohba S, Kawakita D, Hanai N, Koide Y, Sawabe M, Nakata Y, Fukuda Y, Nishikawa D, Takano G, Kimura T, Oguri K, Hirakawa H, Hasegawa Y: Predictive factors for dissection-free sentinel node micrometastases in early oral squamous cell carcinoma. Sci Rep, 13(1):6188, 2023.
  • Kishikawa T, Terada H, Sawabe M, Beppu S, Nishikawa D, Suzuki H, Hanai N: Utilization of ultrasound in photoimmunotherapy for head and neck cancer: a case report. J Ultrasound. 2023 Feb 18. doi: 10.1007/s40477-023-00774-8. Online ahead of print.

邦文論文・商業誌・学会誌その他:5編

2021

英文論文:24編

  • Terada H, Shimode Y, Furukawa M, Sato Y, Hanai N: The Utility of Ultrasonography in the Diagnosis of Cervical Lymph Nodes after Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma. Medicina (Kaunas), 57(5):407,2021.
  • Kariya S, Shimizu Y, Hanai N, Yasumatsu R, Yokota T, Fujii T, Tsukahara K, Yoshida M, Hanyu K, Ueda T, Hirakawa H, Takahashi S, Ono T, Sano D, Yamauchi M, Watanabe A, Omori K, Yamazaki T, Monden N, Kudo N, Arai M, Yonekura S, Asakage T, Fujiwara A, Yamada T, Homma A: Effectiveness of nivolumab affected by prior cetuximab use and neck dissection in Japanese patients with recurrent or metastatic head and neck cancer: results from a retrospective observational study in a real-world setting. Int J Clin Oncol, 26(6):1049-1056,2021.
  • Nishikawa D, Sasaki E, Suzuki H, Beppu S, Sawabe M, Terada H, Sone M, Hanai N: Treatment outcome and pattern of recurrence of sinonasal squamous cell carcinoma with EGFR-mutation and human papillomavirus. J Craniomaxillofac Surg, 49(6):494-500,2021.
  • Motai R, Sawabe M, Kadowaki S, Sasaki E, Nishikawa D, Suzuki H, Beppu S, Terada H, Hanai N: Clinical impact of weekly paclitaxel plus cetuximab is comparable to the EXTREME regimen for recurrent/metastatic head and neck squamous cell carcinoma. Int J Clin Oncol, 26(7):1188-1195,2021.
  • Suzuki H, Abe T, Sasaki R, Nagao T, Murashima A, Fujieda H, Higaki E, Hanai N: Synchronous resection of parotid metastasis with esophagectomy: a case report. In Vivo, 35(4):2337-2340,2021.
  • Hanai N, Shimizu Y, Kariya S, Yasumatsu R, Yokota T, Fujii T, Tsukahara K, Yoshida M, Hanyu K, Ueda T, Hirakawa H, Takahashi S, Ono T, Sano D, Yamauchi M, Watanabe A, Omori K, Yamazaki T, Monden N, Kudo N, Arai M, Sakurai D, Asakage T, Doi I, Yamada T, Homma A: Correction to: Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicentre retrospective clinical study. Int J Clin Oncol, 26(5):1005-1006,2021.
  • Suzuki H, Tamaki T, Terada H, Nishio M, Nishikawa D, Beppu S, Sawabe M, Hanai N: Total lesion glycolysis as a predictor of clinical T3-4a laryngeal cancer with laryngectomy or nonlaryngectomy. Medicine (Baltimore), 100(40):e27427,2021.
  • Suzuki H, Iwaki S, Higaki E, Abe T, Sawabe M, Beppu S, Kobayashi Y, Nishikawa D, Terada H, Hanai N: Supraclavicular Artery Flap for Oral Reconstruction Prior to Esophagectomy During the COVID-19 Pandemic: A Case Report. In Vivo, 35(6):3597-3601,2021.
  • Suzuki H, Sasaki E, Takano G, Goto S, Nishikawa D, Beppu S, Terada H, Sawabe M, Hanai N: Lymph node ratio as a predictor for minor salivary gland cancer in head and neck. BMC Cancer, 21(1):1186,2021.
  • Shiga K, Nibu KI, Fujimoto Y, Asakage T, Homma A, Mitani H, Ogawa T, Okami K, Murono S, Hirano S, Ueda T, Hanai N, Tsukahara K, Ota I, Yoshimoto S, Shinozaki T, Iwae S, Katagiri K, Saito D, Kiyota N, Tahara M, Takahashi F, Hayashi R: Sites of invasion of cancer of the external auditory canal predicting oncologic outcomes. Head Neck, 43(10):3097-3105,2021.
  • Yasumatsu R, Shimizu Y, Hanai N, Kariya S, Yokota T, Fujii T, Tsukahara K, Ando M, Hanyu K, Ueda T, Hirakawa H, Takahashi S, Ono T, Sano D, Yamauchi M, Watanabe A, Omori K, Yamazaki T, Monden N, Kudo N, Arai M, Yonekura S, Asakage T, Nekado T, Yamada T, Homma A: Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study. Int J Clin Oncol, 27(1):95-104,2022.
  • Ishida A, Hanai N, Oki M, Iwakoshi A: Successful Resection of a Primary Dedifferentiated Tracheal Liposarcoma Causing Tracheal Stenosis. Intern Med, 61(5):719-722,2022.
  • Nakano S, Okumura Y, Murase T, Nagao T, Kusafuka K, Urano M, Yamamoto H, Kano S, Tsukahara K, Okami K, Kawakita D, Nagao T, Hanai N, Iwai H, Kawata R, Tada Y, Nibu KI, Inagaki H: Salivary mucoepidermoid carcinoma: Histological variants, grading systems, CRTC1/3-MAML2 fusions, and clinicopathological features. Histopathology, 80(4):729-735,2022.
  • Suzuki H, Tamaki T, Kodaira T, Nishio M, Nishikawa D, Beppu S, Terada H, Sawabe M, Hanai N: Metabolic tumour volume as a predictor of survival for sinonasal tract squamous cell carcinoma. Diagnostics (Basel), 12(1):146,2022.
  • Suzuki H, Yokoi M, Hagiwara S, Sasaki E, Kobayashi Y, Iwaki S, Nishikawa D, Beppu S, Terada H, Sawabe M, Hanai N: A case of salvage maxillectomy for recurrent oral cancer after boron neutron capture therapy during the COVID-19 pandemic. Anticancer Res, 42(3):1653-1657,2022.

邦文論文・商業誌・学会誌その他:7編

学会発表

2023年度

  • 外国学会:8回
  • 国内学会・研究会:60回

2022年度

  • 外国学会:2回
  • 国内学会・研究会:97回

2021年度

  • 外国学会:0回
  • 国内学会・研究会:83回